Terms: = Lymphoma AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406
19 results:
1.
Bulutay P; Vatansever D; Taskiran C; Mericoz CA; Tokat F; Kapucuoglu N; Kulac I
Indian J Pathol Microbiol; 2023; 66(2):392-395. PubMed ID: 37077094
[TBL] [Abstract] [Full Text] [Related]
2. Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!
Cordier F; Van der Meulen J; van Roy N; De Wilde J; van Dijck H; Vanhoenacker F; Lambrechts M; Noyez V; Van de Vijver K; Ferdinande L; Dendooven A; Van Dorpe J; Creytens D
Pathol Res Pract; 2022 Mar; 231():153772. PubMed ID: 35074700
[TBL] [Abstract] [Full Text] [Related]
3. Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 Cases.
Argani P; Lian DWQ; Agaimy A; Metzler M; Wobker SE; Matoso A; Epstein JI; Sung YS; Zhang L; Antonescu CR
Am J Surg Pathol; 2021 May; 45(5):653-661. PubMed ID: 33399341
[TBL] [Abstract] [Full Text] [Related]
4. EZH2-Targeted Therapies in Cancer: Hype or a Reality.
Eich ML; Athar M; Ferguson JE; Varambally S
Cancer Res; 2020 Dec; 80(24):5449-5458. PubMed ID: 32978169
[TBL] [Abstract] [Full Text] [Related]
5. Current applications of molecular testing on body cavity fluids.
Pinto D; Schmitt F
Diagn Cytopathol; 2020 Sep; 48(9):840-851. PubMed ID: 32227635
[TBL] [Abstract] [Full Text] [Related]
6. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant lymphomas.
Yamagishi M; Hori M; Fujikawa D; Ohsugi T; Honma D; Adachi N; Katano H; Hishima T; Kobayashi S; Nakano K; Nakashima M; Iwanaga M; Utsunomiya A; Tanaka Y; Okada S; Tsukasaki K; Tobinai K; Araki K; Watanabe T; Uchimaru K
Cell Rep; 2019 Nov; 29(8):2321-2337.e7. PubMed ID: 31747604
[TBL] [Abstract] [Full Text] [Related]
7. The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice.
Nahon-Esteve S; Martel A; Maschi C; Caujolle JP; Baillif S; Lassalle S; Hofman P
Curr Mol Med; 2019; 19(9):632-664. PubMed ID: 31418658
[TBL] [Abstract] [Full Text] [Related]
8. Diagnosis and characterization of malignant effusions through pleural fluid cytological examination.
Porcel JM
Curr Opin Pulm Med; 2019 Jul; 25(4):362-368. PubMed ID: 31082996
[TBL] [Abstract] [Full Text] [Related]
9. Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Porcel JM
Ther Adv Respir Dis; 2018; 12():1753466618808660. PubMed ID: 30354850
[TBL] [Abstract] [Full Text] [Related]
10. Immunoexpression of bap1, ROS1, and ALK in Spitzoid Melanocytic Tumors.
Cardili L; Viana CR; Germano A; Fernandes M; Barcellos D; Landman G
Int J Surg Pathol; 2018 Sep; 26(6):514-520. PubMed ID: 29623743
[TBL] [Abstract] [Full Text] [Related]
11. Malignant Mesothelioma in Individuals With Nonmesothelial Neoplasms.
Butnor KJ; Pavlisko EN; Sporn TA; Roggli VL
Arch Pathol Lab Med; 2018 Jun; 142(6):730-734. PubMed ID: 29528717
[TBL] [Abstract] [Full Text] [Related]
12. Remodeling of Ca
Ando H; Kawaai K; Bonneau B; Mikoshiba K
Adv Biol Regul; 2018 May; 68():64-76. PubMed ID: 29287955
[TBL] [Abstract] [Full Text] [Related]
13. Malignant Peripheral Nerve Sheath Tumor in a Patient With bap1 Tumor Predisposition Syndrome.
Kaszuba MC; Pulido JS; Folpe AL; Pichurin PN; Goodenberger ML; Spinner RJ
World Neurosurg; 2018 Jan; 109():362-364. PubMed ID: 29061454
[TBL] [Abstract] [Full Text] [Related]
14. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
[TBL] [Abstract] [Full Text] [Related]
15. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.
Jusakul A; Cutcutache I; Yong CH; Lim JQ; Huang MN; Padmanabhan N; Nellore V; Kongpetch S; Ng AWT; Ng LM; Choo SP; Myint SS; Thanan R; Nagarajan S; Lim WK; Ng CCY; Boot A; Liu M; Ong CK; Rajasegaran V; Lie S; Lim AST; Lim TH; Tan J; Loh JL; McPherson JR; Khuntikeo N; Bhudhisawasdi V; Yongvanit P; Wongkham S; Totoki Y; Nakamura H; Arai Y; Yamasaki S; Chow PK; Chung AYF; Ooi LLPJ; Lim KH; Dima S; Duda DG; Popescu I; Broet P; Hsieh SY; Yu MC; Scarpa A; Lai J; Luo DX; Carvalho AL; Vettore AL; Rhee H; Park YN; Alexandrov LB; Gordân R; Rozen SG; Shibata T; Pairojkul C; Teh BT; Tan P
Cancer Discov; 2017 Oct; 7(10):1116-1135. PubMed ID: 28667006
[TBL] [Abstract] [Full Text] [Related]
16. Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.
Ugurluer G; Chang K; Gamez ME; Arnett AL; Jayakrishnan R; Miller RC; Sio TT
Anticancer Res; 2016 May; 36(5):2331-8. PubMed ID: 27127140
[TBL] [Abstract] [Full Text] [Related]
17. Spitz Tumors: Comparison of Histological Features in Relationship to Immunohistochemical Staining for ALK and NTRK1.
Kiuru M; Jungbluth A; Kutzner H; Wiesner T; Busam KJ
Int J Surg Pathol; 2016 May; 24(3):200-6. PubMed ID: 26873340
[TBL] [Abstract] [Full Text] [Related]
18. Functional and cancer genomics of ASXL family members.
Katoh M
Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
[TBL] [Abstract] [Full Text] [Related]
19. Genetics of primary intraocular tumors.
Nagarkatti-Gude N; Wang Y; Ali MJ; Honavar SG; Jager MJ; Chan CC
Ocul Immunol Inflamm; 2012 Aug; 20(4):244-54. PubMed ID: 22834783
[TBL] [Abstract] [Full Text] [Related]
